The Vancouver Sun on MSN

B.C. childhood immunization rates haven't recovered from COVID-19 slump. Here's why

As many British Columbians received text messages urging them to book their seasonal flu and COVID shots this week, ...
The Malaysian Reserve

Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the ...